Cowen & Co
http://www.cowen.com/default.htmlCowen and Company offers investment banking services, including equity research, equity and convertible debt financings, mergers and acquisitions advisory services, and restricted security sales.
-
Spark Therapeutics (ONCE) PT Lowered to $80 at Cowen
-
Spark Therapeutics to Participate in Multiple Conferences in March
-
Spark Therapeutics to Participate in Multiple Conferences in March
-
Spark Therapeutics to Participate in Multiple Conferences in March
-
Spark Therapeutics (ONCE) PT Lowered to $85 at Cowen; Says Shares Remain Undervalued
-
Spark Therapeutics (ONCE) Data Suggest Dosing Work Needed, But Weakness 'Overdone' - Cowen
-
Spark Therapeutics Announces Closing of Public Offering
-
Spark Therapeutics Announces Pricing of $350.0 Million Public Offering
-
Spark Therapeutics (ONCE) to Offer $300M in Common Stock
-
Spark Therapeutics Announces Proposed Public Offering of Common Stock
-
Spark Therapeutics (ONCE) PT Raised to $95 at Cowen
-
Spark Therapeutics to Participate in Multiple Conferences in March
-
Spark Therapeutics Announces Closing of Public Offering
-
Spark Therapeutics (ONCE) Prices 3.5M Common Stock Offering at $45/Share
-
Spark Therapeutics Announces Pricing of Public Offering
-
Spark Therapeutics (ONCE) Commences 3.5M Share Stock Offering
-
Spark Therapeutics Announces Launch of Public Offering
-
Pre-Open Stock Movers 06/03: (TLN) (IMMU) (AMBA) Higher; (WRES) (ONTY) (ZUMZ) Lower (more...)
-
Notable Analyst Rating Changes 3/31: (OIS) (MT) (FTNT) Upgraded; (TGT) (RAX) (SQ) Downgraded
-
Spark Therapeutics Announces Cowen Healthcare Conference Participation
-
Spark Therapeutics (ONCE) Prices 3M Common Offering at $47/Share
-
Spark Therapeutics Announces Pricing of Public Offering
-
Spark Therapeutics (ONCE) Announces 3M Common Stock Offering
-
Spark Therapeutics Announces Launch of Public Offering
-
Cowen Remains Bullish After Meeting with Spark Therapeutics (ONCE)
-
Streetinsider.com's Hot Lunchtime Reads 10/5: (AAPL) (ONCE) (TWTR) (BLUE)
-
Cowen Remains Bullish on Spark Therapeutics (ONCE) Following Top-Line SPK-RPE65 Results
-
UPDATE: Cowen Starts Spark Therapeutics (ONCE) at Outperform
-
Spark Therapeutics (ONCE) IPO Opens Up 96%
-
Spark Therapeutics (ONCE) Prices 7M Common IPO at $23/Share, Above Expected Range
-
Spark Therapeutics (ONCE) Boosts Expected IPO Price Range
-
Spark Therapeutics (ONCE) Files $86.25M IPO

